Valeant (NYSE: VRX) and the Beginning of an M&A Wave

Valeant Pharmaceuticals International Inc. (NYSE: VRX) and activist investor Bill Ackman announced an unsolicited takeover proposal of Botox maker Allergan Inc. (NYSE: AGN) for $47 billion on Tuesday. According to Money Morning's Capital Wave Strategist Shah Gilani, that move signals the beginning of an M&A wave that is set to hit the market. Watch Gilani's appearance on FOX Business' "Varney & Co." Tuesday, and see why this potential deal is so exciting for the market.


Valeant (NYSE: VRX) and Bill Ackman made a $47 billion bid for Botox maker Allergan Tuesday. See why that’s exciting news for the markets.

Gas prices are climbing, but it's not all bad news. Here's how you can start profiting from this sector today...